Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. PIMA547968

Invitrogen™ Volociximab Chimeric Recombinant Rabbit Monoclonal Antibody (M200 (Volociximab))
GREENER_CHOICE

Catalog No. PIMA547968
Change view
Click to view available options
Quantity:
200 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
PIMA547968 200 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. PIMA547968 Supplier Invitrogen™ Supplier No. MA547968
Only null left
Add to Cart
Add to Cart

Description

Rabbit Recombinant Monoclonal Antibody

Specificity: The antibody binds to human alpha-5Beta1 integrin with a Kd of 0.367 nM, an EC50 of 0.2 nM and an IC50 of 2.3 nM.

Volociximab is a biosimilar that targets ITGA5.
TRUSTED_SUSTAINABILITY

Specifications

Antigen Volociximab Chimeric
Applications ELISA, Flow Cytometry, Inhibition Assays, Immunohistochemistry, Immunocytochemistry
Classification Recombinant Monoclonal
Clone M200 (Volociximab)
Concentration 1 mg/mL
Conjugate Unconjugated
Formulation PBS with 0.02% ProClin 300
Gene Alias 558480-40-3; M20
Host Species Rabbit
Immunogen Heterodimeric alpha-5-Beta-1Fc fusion protein.
Purification Method Protein A
Quantity 200 μg
Regulatory Status RUO
Primary or Secondary Primary
Target Species Human
Content And Storage Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Product Type Antibody
Form Liquid
Isotype IgG κ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.